BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28751461)

  • 21. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
    Weaver JMJ; Ross-Innes CS; Shannon N; Lynch AG; Forshew T; Barbera M; Murtaza M; Ong CJ; Lao-Sirieix P; Dunning MJ; Smith L; Smith ML; Anderson CL; Carvalho B; O'Donovan M; Underwood TJ; May AP; Grehan N; Hardwick R; Davies J; Oloumi A; Aparicio S; Caldas C; Eldridge MD; Edwards PAW; Rosenfeld N; Tavaré S; Fitzgerald RC;
    Nat Genet; 2014 Aug; 46(8):837-843. PubMed ID: 24952744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
    Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
    Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma.
    Kaz AM; Luo Y; Dzieciatkowski S; Chak A; Willis JE; Upton MP; Leidner RS; Grady WM
    Genes Chromosomes Cancer; 2012 Apr; 51(4):384-93. PubMed ID: 22170739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
    Bansal A; Gupta V; Wang K
    J Cell Biochem; 2016 Jun; 117(6):1288-95. PubMed ID: 26808728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.
    Streppel MM; Lata S; DelaBastide M; Montgomery EA; Wang JS; Canto MI; Macgregor-Das AM; Pai S; Morsink FH; Offerhaus GJ; Antoniou E; Maitra A; McCombie WR
    Oncogene; 2014 Jan; 33(3):347-57. PubMed ID: 23318448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential biomarkers in Barrett's esophagus derived esophageal adenocarcinoma.
    Yi N; Zhao H; He J; Xie X; Liang L; Zuo G; Xiong M; Liang Y; Yi T
    Sci Rep; 2023 Feb; 13(1):2345. PubMed ID: 36759514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
    Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
    Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal Adenocarcinoma.
    O'Farrell NJ; Phelan JJ; Feighery R; Doyle B; Picardo SL; Ravi N; O'Toole D; Reynolds JV; O'Sullivan J
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
    Kaz AM; Wong CJ; Luo Y; Virgin JB; Washington MK; Willis JE; Leidner RS; Chak A; Grady WM
    Epigenetics; 2011 Dec; 6(12):1403-12. PubMed ID: 22139570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a primitive intestinal transcription factor network shared between esophageal adenocarcinoma and its precancerous precursor state.
    Rogerson C; Britton E; Withey S; Hanley N; Ang YS; Sharrocks AD
    Genome Res; 2019 May; 29(5):723-736. PubMed ID: 30962179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
    Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
    BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trefoil factor 1 inhibits the development of esophageal adenocarcinoma from Barrett's epithelium.
    Hasebe K; Yamazaki K; Yamaguchi J; Kokuryo T; Yokoyama Y; Miyata K; Fukaya M; Nagino M; Ebata T
    Lab Invest; 2022 Aug; 102(8):885-895. PubMed ID: 35279702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
    Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma.
    van Nistelrooij AMJ; van Marion R; van Ijcken WFJ; de Klein A; Wagner A; Biermann K; Spaander MCW; van Lanschot JJB; Dinjens WNM; Wijnhoven BPL
    Fam Cancer; 2018 Jul; 17(3):435-440. PubMed ID: 29134539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.
    Doucet-O'Hare TT; Rodić N; Sharma R; Darbari I; Abril G; Choi JA; Young Ahn J; Cheng Y; Anders RA; Burns KH; Meltzer SJ; Kazazian HH
    Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4894-900. PubMed ID: 26283398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.
    Alvi MA; Liu X; O'Donovan M; Newton R; Wernisch L; Shannon NB; Shariff K; di Pietro M; Bergman JJ; Ragunath K; Fitzgerald RC
    Clin Cancer Res; 2013 Feb; 19(4):878-88. PubMed ID: 23243219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.